Cargando…
Autophagy as a therapeutic target in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is characterised by early metastasis and resistance to anti-cancer therapy, leading to an overall poor prognosis. Despite continued research efforts, no targeted therapy has yet shown meaningful efficacy in PDAC; mutations in the oncogene KRAS and the tumour s...
Autores principales: | Piffoux, Max, Eriau, Erwan, Cassier, Philippe A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852577/ https://www.ncbi.nlm.nih.gov/pubmed/32929194 http://dx.doi.org/10.1038/s41416-020-01039-5 |
Ejemplares similares
-
Metabolic Reprogramming by Reduced Calorie Intake or Pharmacological Caloric Restriction Mimetics for Improved Cancer Immunotherapy
por: Eriau, Erwan, et al.
Publicado: (2021) -
Targeting autophagy as a therapeutic strategy against pancreatic cancer
por: Yamamoto, Keisuke, et al.
Publicado: (2022) -
Therapeutic Aspects and Molecular Targets of Autophagy to Control Pancreatic Cancer Management
por: Rahman, Md. Ataur, et al.
Publicado: (2022) -
Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
por: Raufi, Alexander G., et al.
Publicado: (2021) -
Therapeutic Targeting of Autophagy()
por: Towers, Christina G., et al.
Publicado: (2016)